Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Thomas

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Analytical Chemistry|April 1, 1997
NIST/NCI Micronutrients Measurement Quality Assurance Program: measurement repeatabilities and reproducibilities for fat-soluble vitamin-related compounds in human seraD L Duewer, J B Thomas, M C Kline, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptorJ B Thomas, R N Atkinson, X M Herault, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 1999
(+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptorJ B Thomas, X M Herault, R B Rothman, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 8, 2001
Use of contrast echocardiography in the diagnosis of subacute myocardial rupture after myocardial infarctionM A García-Fernández, R O Macchioli, P M Moreno, et al.
Journal of Medicinal Chemistry|June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonistsJ B Thomas, S W Mascarella, R B Rothman, et al.
American Journal of Veterinary Research|June 13, 2001
Selenium status of cats in four regions of the world and comparison with reported incidence of hyperthyroidism in cats in those regionsD J Foster, K L Thoday, J R Arthur, et al.
Journal of AOAC International|May 1, 1997
Certification of nutrients in Standard Reference Material 1846: infant formulaK E Sharpless, S B Schiller, S A Margolis, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonistsJ B Thomas, S W Mascarella, J P Burgess, et al.
Journal of Medicinal Chemistry|April 13, 2001
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamidesJ B Thomas, X M Herault, R B Rothman, et al.
Journal of Medicinal Chemistry|October 10, 1998
N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonistsJ B Thomas, X Zheng, S W Mascarella, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Analytical Chemistry|April 1, 1997
NIST/NCI Micronutrients Measurement Quality Assurance Program: measurement repeatabilities and reproducibilities for fat-soluble vitamin-related compounds in human seraD L Duewer, J B Thomas, M C Kline, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptorJ B Thomas, R N Atkinson, X M Herault, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 1999
(+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptorJ B Thomas, X M Herault, R B Rothman, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 8, 2001
Use of contrast echocardiography in the diagnosis of subacute myocardial rupture after myocardial infarctionM A García-Fernández, R O Macchioli, P M Moreno, et al.
Journal of Medicinal Chemistry|June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonistsJ B Thomas, S W Mascarella, R B Rothman, et al.
American Journal of Veterinary Research|June 13, 2001
Selenium status of cats in four regions of the world and comparison with reported incidence of hyperthyroidism in cats in those regionsD J Foster, K L Thoday, J R Arthur, et al.
Journal of AOAC International|May 1, 1997
Certification of nutrients in Standard Reference Material 1846: infant formulaK E Sharpless, S B Schiller, S A Margolis, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonistsJ B Thomas, S W Mascarella, J P Burgess, et al.
Journal of Medicinal Chemistry|April 13, 2001
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamidesJ B Thomas, X M Herault, R B Rothman, et al.
Journal of Medicinal Chemistry|October 10, 1998
N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonistsJ B Thomas, X Zheng, S W Mascarella, et al.
Pageof 13